We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Blood Test Detects Brain Damage in Amateur Boxers

By LabMedica International staff writers
Posted on 27 Aug 2009
A blood test detected brain damage in amateur boxers even after a two-month break from boxing. More...


Blood samples were collected from 44 Turkish amateur boxers at the beginning of a training camp after a two-month break from boxing. The results were compared to those found in a healthy control group. Scientists analyzed several proteins that can be used to identify brain damage, and found that the levels of one protein, called neuron-specific enolase (NSE), were higher among the boxers than in the control group.

The study was conducted by investigators at the Sahlgrenska Academy at the University of Gothenburg (Sweden) and the Erciyes University Medical School (Kayseri, Turkey). The findings also demonstrated that repeated blows to the head might damage the brain.

"The blows seem to lead to a deterioration of nerve cells that lasts for a relatively long time. It is important that this is made known to participants in sports that involve kicks and blows to the head and to parents who let their children participate," said Henrik Zetterberg, reader in psychiatry and neurochemistry at the Sahlgrenska Academy. "Their levels were high even after two months off from boxing. This indicates that the harmful processes in the brain continue even if the boxers have not recently experienced head trauma," he concluded.

This type of biomarker could be very useful in sports medicine to determine when an athlete should abstain from training and competition.

The study was published in the August 9, 2009 issue of the journal Brain Injury.

Related Links:

Sahlgrenska Academy
Erciyes University Medical School




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.